Загрузка...
Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer
Data from over 20 years ago demonstrated potential use for insulin-like growth factor (IGF) signaling modulators, specifically with IGF-1R antagonists, in a variety of pediatric and adolescent cancers, particularly in sarcomas. However, in spite of promising preclinical data, IGF-1R inhibitors have...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3563098/ https://ncbi.nlm.nih.gov/pubmed/23383402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2013.00009 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|